Immunotherapy for advanced or metastatic urothelial carcinoma

Maisch P, Hwang EC, Narayan V, Bakker CJ, Kunath F, Dahm P (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Cohrane Library Update Software Ltd.

Book Volume: 2020

Article Number: CD013774

Journal Issue: 11

DOI: 10.1002/14651858.CD013774

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.

Authors with CRIS profile

Frank Kunath Urologische Klinik

Involved external institutions

University of Minnesota (UMN) US United States (USA) (US) Chonnam National University (CNU) / 전남대학교 KR Korea, Republic of (KR) Va Midwest Health Care Network US United States (USA) (US) Emory University US United States (USA) (US) Klinikum rechts der Isar DE Germany (DE)

How to cite

APA:

Maisch, P., Hwang, E.C., Narayan, V., Bakker, C.J., Kunath, F., & Dahm, P. (2020). Immunotherapy for advanced or metastatic urothelial carcinoma. Cohrane Library, 2020(11). https://doi.org/10.1002/14651858.CD013774

MLA:

Maisch, Philipp, et al. "Immunotherapy for advanced or metastatic urothelial carcinoma." Cohrane Library 2020.11 (2020).

BibTeX: Download